MWNA
CO

Marshall Wace North America’s Global Cord Blood Corporation CO Stock Holding History

Marshall Wace North America’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-45,086
Closed -$460K – 1925
2018
Q1 		$460K Buy
+45,086
New +$461K ﹤0.01% 1170

Other funds holding CO

JCM
Jayhawk Capital Management Shawnee, Kansas $59.9M AUM 22.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
SAM
Silphium Asset Management London, United Kingdom $297M AUM 28.02% 1-Year Est. Return
PG
PEAK6 Group Chicago, Illinois $23.4B AUM 17.65% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return

Marshall Wace North America's CO Position: Q2 2018 in Review

Marshall Wace North America sold out of Global Cord Blood Corporation (CO) in Q2 2018, closing a stake of 45,086 shares — an estimated $460K sold.

Marshall Wace North America first reported a position in CO in Q1 2018 and held it in 1 quarter. The position peaked at $460K in Q1 2018. 46 funds tracked by Wall St. Rank hold CO as of Q2 2018.

  • Marshall Wace North America reported no remaining Global Cord Blood Corporation position as of Q2 2018 after selling out during the quarter.
  • Marshall Wace North America sold 45,086 Global Cord Blood Corporation shares in Q2 2018, an estimated $460K.
  • Marshall Wace North America first reported a position in Global Cord Blood Corporation in Q1 2018 and held it in 1 quarter.
  • Marshall Wace North America's Global Cord Blood Corporation position peaked at $460K in Q1 2018.
  • 46 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2018.

Based on Marshall Wace North America's 13F filing for Q2 2018, filed 14 Aug 2018.